July 29
2:00 pm - 3:00 pm EDT


The neurosciences comeback: After a lengthy chill, Big Pharma is warming back up to neuro

Neurosciences became the stepchild of the pharma industry after a series of ugly setbacks in the clinic drove away the major players. But now, considering the advances in genetics and some new work on old ideas, some of the biggest outfits are driving a comeback of sorts as they team up or buy out some of the upstarts in this space. Endpoints examines the trend, and where it appears we’re headed now.

register now
register for the webinar

No cost to register, subject to confirmation

By registering for this event, you accept that you may receive direct communication from the sponsor(s).

If you are experiencing problems with your registration, please try the Zoom registration page.